Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension

被引:1
作者
Sato, Koichi
Dohi, Yasuaki
Kojima, Masayoshi
Miyagawa, Koichi
Takase, Hiroyuki
Katada, Eiichi
Suzuki, Shin
机构
[1] Nagaya City Johoku Hosp, Dept Internal Med, Div Clin Res Hypertens, Kita Ku, Nagoya, Aichi 4620033, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Div Hypertens & Vasc Res Internal Med & Mol Sci, Nagoya, Aichi 467, Japan
[3] Tsushima City Hosp, Dept Neurol, Tsushima, Japan
来源
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH | 2006年 / 56卷 / 07期
关键词
antihypertensives; antioxidants; ascorbic acid; effects on blood pressure; elderly hypertensive patients; blood pressure monitoring; ambulatory; CAS; 50-81-7; refractory hypertension;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The increased production of reactive oxygen species plays a role in the etiology of hypertension, but the effects of antioxidants on blood pressure are controversial. However, antioxidants possibly lower blood pressure in elderly patients with hypertension, because vascular aging is also closely related to oxidative stress. Effects of chronic treatment with ascorbic acid (CAS 50-81-7; 600 mg/day for 6 months) on blood pressure and levels of C-reactive protein, 8-isoprostane, and malondialdehyde-modified low-density lipoproteins were examined in elderly patients (n = 12, six males/six females, age 78.3 +/- 5.0 years, mean +/- SD [range, 67 to 84 years]; elderly group) and adult patients (n = 12, five males/seven females, age 54.6 +/- 6.7 years [range, 39 to 62]; adult group) with refractory hypertension. Chronic treatment with ascorbic acid markedly reduced systolic blood pressure and pulse pressure in ambulatory blood pressure monitoring in the elderly group (from 154.9 +/- 21.6 to 134.8 +/- 19.7 mmHg, p < 0.001; and from 79.1 +/- 22.1 to 63.4 +/- 18.7, p < 0.05; respectively), which was accompanied by an increase in the serum levels of ascorbic acid and decreases in the levels of C-reactive protein, 8-isoprostane, and malondialdehyde-modified low-density lipoproteins. In contrast, ascorbic acid did not affect blood pressure in the adult group. These results suggest that ascorbic acid is useful for controlling blood pressure in elderly patients with refractory hypertension.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 33 条
  • [1] ARTERIAL STIFFNESS - A NEW CARDIOVASCULAR RISK FACTOR
    ARNETT, DK
    EVANS, GW
    RILEY, WA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (08) : 669 - 682
  • [2] Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period
    Benetos, A
    Adamopoulos, C
    Bureau, JM
    Temmar, M
    Labat, C
    Bean, K
    Thomas, F
    Pannier, B
    Asmar, R
    Zureik, M
    Safar, M
    Guize, L
    [J]. CIRCULATION, 2002, 105 (10) : 1202 - 1207
  • [3] AGE-RELATED-CHANGES IN VASCULAR SMOOTH-MUSCLE AND ENDOTHELIUM
    DOHI, Y
    KOJIMA, M
    SATO, K
    LUSCHER, TF
    [J]. DRUGS & AGING, 1995, 7 (04) : 278 - 291
  • [4] Treatment of hypertension with ascorbic acid
    Duffy, SJ
    Gokce, N
    Holbrook, M
    Huang, A
    Frei, B
    Keaney, JF
    Vita, JA
    [J]. LANCET, 1999, 354 (9195) : 2048 - 2049
  • [5] VITAMIN-C INTAKE AND MORTALITY AMONG A SAMPLE OF THE UNITED-STATES POPULATION
    ENSTROM, JE
    KANIM, LE
    KLEIN, MA
    [J]. EPIDEMIOLOGY, 1992, 3 (03) : 194 - 202
  • [6] A DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL TRIAL OF VITAMIN-C TREATMENT IN ELDERLY PATIENTS WITH HYPERTENSION
    GHOSH, SK
    EKPO, EB
    SHAH, IU
    GIRLING, AJ
    JENKINS, C
    SINCLAIR, AJ
    [J]. GERONTOLOGY, 1994, 40 (05) : 268 - 272
  • [7] Harrison D, 2003, AM J CARDIOL, V91, p7A
  • [8] Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
  • [9] Kalpana T, 2001, ARZNEIMITTEL-FORSCH, V51, P633
  • [10] Karunakar N, 2003, ARZNEIMITTEL-FORSCH, V53, P254